Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi‐Country Needs Assessment
The study explored current knowledge, skills and confidence levels of oncologists, hematologists and hematologist-oncologists (ONC/HEM) across Brazil, France, Germany, UK, and the US.
It identified the challenges they experienced when managing and monitoring treatment and engaged patients with CLL or MCL in shared decision-making, with a long-term objective to inform evidence-based continuing medical education to optimize ONC/HEM competencies.
Key findings highlighted opportunities to strengthen healthcare professional competencies to identify and manage side effects associated with treatments for CLL or MCL, patient risk stratification and engaging patients in shared decision-making.
This study was made possible through independent medical education funds provided by Eli Lilly & Company.
Read the full article: https://doi.org/10.1002/cnr2.70655